Concomitant chemoradiotherapy for non-small cell lung cancer

Lung Cancer. 1994 Mar:10 Suppl 1:S253-61. doi: 10.1016/0169-5002(94)91689-6.

Abstract

Concomitant chemoradiotherapy represents an investigational approach to the treatment of locoregionally advanced non-small cell lung cancer. The theoretical rationale, and clinical experience are reviewed in brief. Clinical trials conducted at the University of Chicago are summarized.

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Carcinoma, Non-Small-Cell Lung / radiotherapy
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Chicago / epidemiology
  • Cisplatin / administration & dosage
  • Clinical Trials as Topic
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Combined Modality Therapy
  • Fluorouracil / administration & dosage
  • Humans
  • Hydroxyurea / administration & dosage
  • Immunologic Factors / therapeutic use
  • Interferon-alpha / therapeutic use
  • Leucovorin / administration & dosage
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / mortality
  • Lung Neoplasms / radiotherapy
  • Lung Neoplasms / therapy*
  • Pilot Projects
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Immunologic Factors
  • Interferon-alpha
  • Cisplatin
  • Leucovorin
  • Fluorouracil
  • Hydroxyurea